Df Dent & CO Inc Castle Biosciences Inc Transaction History

Df Dent & CO Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$16.0 - $45.99 $1.66 Million - $4.77 Million	-103,810 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$33.17 - $46.98 $509,458 - $721,565	15,359 Added 17.36%	103,810 $4.66 Million
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $472,977 - $818,326	-12,109 Reduced 12.04%	88,451 $3.79 Million
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $382,426 - $493,535	6,360 Added 6.75%	100,560 $6.69 Million
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $343,329 - $526,480	6,857 Added 7.85%	94,200 $6.91 Million
Q1 2021 May 17, 2021	BUY	$58.92 - $97.33 $2.75 Million - $4.53 Million	46,591 Added 114.33%	87,343 $5.98 Million
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $1.78 Million - $2.98 Million	40,752 New	40,752 $2.74 Million

202

26M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $779M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Df Dent & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Df Dent & CO Inc with notifications on news.